tickrz reports
  
tickrz rank
D
CME Group Inc (CME)
Financial | Investment Brokerage - National
CEO: Terrence A. Duffy
Employees: 2530
cmegroup.com
FACTOR RANKINGSFACTOR SCREENER 
Pure Value Rank333Dividend Rank416
Moat Rank452Financial Strength Rank377
Growth Rank367Momentum Rank130
DIVIDEND ANALYSIS
Dividend Yield2.11%
Payout Ratio123.27%
3 yr Dividend Growth10.06%
VALUATION RATIOS
P/E Ratio25.36x
P/B Ratio1.93x
P/S Ratio11.06x
EV/EBITDA Ratio16.59x
FINANCIAL STRENGTH
Piotroski F-ScoreNOT AVAILABLE
Debt-to-Equity11%
Interest Coverage0x
MOAT
ROE7.57%
ROIC6.3%
Net Margin41.56%
GROWTH
5 yr EPS Growth-3.56%
5 yr SPS Growth2.39%
5 yr BPS Growth-1.6%
CME Group Inc's stock has climbed 22% over the last year, earning it a strong Momentum Rank
 tickrz summary
CME Group Inc receives a D ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
 value
 pure value ranking Warren Buffett ranking
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. CME Group Inc's valuation score is comprised of a P/E ratio of 25.4x, a P/B ratio of 1.9x, a P/S ratio of 11.1x, and an EV/EBITDA ratio of 16.6x. CME Group Inc ranks 333 out of the S&P 500 constituents on valuation--a relatively weak score.CME Group Inc ranks 398 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, CME Group Inc is probably not for you.

 quality
 moat financial strength
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Financial sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance. Interest coverage of 0x, a debt/equity ratio of 11% and a Moat Rank of 452 translate to a weak Financial Strength score.


 momentum
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 22.33% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 130. CME Group Inc's strong 12 month stock performance will appeal to momentum investors.

 yield
 value + yield
Shares currently yield 2.11%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, CME Group Inc ranks 416 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

 growth
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the bottom third of S&P500 companies. Its -3.6% 5 year annualized EPS growth, 2.4% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of -1.6% speak to its relatively poor ranking.

CME Group Inc (CME)
Financial | Investment Brokerage - National
CEO: Terrence A. Duffy
Employees: 2530
cmegroup.com


tickrz rank
D

VALUATION RATIOS
P/E Ratio25.36x
P/B Ratio1.93x
P/S Ratio11.06x
EV/EBITDA Ratio16.59x
DIVIDEND ANALYSIS
Dividend Yield2.11%
Payout Ratio123.27%
3 yr Dividend Growth10.06%
FINANCIAL STRENGTH
Piotroski F-ScoreNOT AVAILABLE
Debt-to-Equity11%
Interest Coverage0x
MOAT
ROE7.57%
ROIC6.3%
Net Margin41.56%
GROWTH
5 yr EPS Growth-3.56%
5 yr SPS Growth2.39%
5 yr BPS Growth-1.6%

TICKRZ RANK
CME Group Inc receives a D ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. CME Group Inc's valuation score is comprised of a P/E ratio of 25.4x, a P/B ratio of 1.9x, a P/S ratio of 11.1x, and an EV/EBITDA ratio of 16.6x. CME Group Inc ranks 333 out of the S&P 500 constituents on valuation--a relatively weak score.

WARREN BUFFETT RANKING
CME Group Inc ranks 398 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, CME Group Inc is probably not for you.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Financial sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.

FINANCIAL STRENGTH
Interest coverage of 0x, a debt/equity ratio of 11% and a Moat Rank of 452 translate to a weak Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 22.33% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 130. CME Group Inc's strong 12 month stock performance will appeal to momentum investors.

VALUE + YIELD
Shares currently yield 2.11%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, CME Group Inc ranks 416 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the bottom third of S&P500 companies. Its -3.6% 5 year annualized EPS growth, 2.4% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of -1.6% speak to its relatively poor ranking.